AHCL · Health Care · 2026-08-07

Anlon Healthcare Ltd

MARKET: BULL TOPPING · 2026-08-07
₹14.6
+2.39% today
₹773 Cr · Small cap
About this companyHealth Care· Pharmaceuticals
Expand ▾

Anlon Healthcare Limited manufactures and sells advance pharmaceutical intermediates in India and internationally. The company offers active pharmaceutical ingredients (API); nutraceutical API products; personal care ingredients; and veterinary API products. Its products are used in anti-inflammatory (NSAID), analgesic, antipyretic, antihistamine, antidepressant, antipsychotic, anticoagulant, antihypertensive, nutrition, anti-arrhythmic, anti-hyper parathyroid, antiplatelet, ant diabetic, gastroesophageal reflux disease (GERD), and anti-rheumatic therapeutics areas. The company was incorporated in 2013 and is based in Rajkot, India.

Visit company website →
P/E (TTM)
21.9
Forward —
vs 52W High
—
Stock is basing below old highs. A volume-backed breakout to new highs would be the Stage 2 signal to watch.
Stage Maturity
Week 18
1w13w26w
Week 18 — proven structure, sweet spot
How long this stock has been basing. Longer bases can produce stronger breakouts — but don't anticipate, wait for the breakout.
vs 200 DMA
—
—
Stock is testing its 200 DMA as part of the base. Reclaiming and holding above it is a key Stage 2 prerequisite.
Rel Volume
0.51x
vs 50-day avg
Volume in Stage 1 basing is typically quiet. A surge in volume on an upside breakout is the signal to watch.
Trend Health
↓
MA20 rolling over · -2.6% vs MA50 +3.9%
Two-layer momentum read: the glyph shows whether the 20-day MA is rising (↑/↗), flat (→), or rolling over (↓). The ⇈ flag fires when the 20-day MA is pulling away from the 50-day MA — short-term momentum building on top of the longer trend. Best when both glyphs agree.
Sector
Health Care
↑ Building
Stage 2%
51.6%
20d Δ
+1.6pp
1M return
+3.1%
3M return
+11.6%
Sector Stage-2 % · last 20 days
Sector has 79 Stage 2 leaders. See Health Care Stage 2 →
Industry
Pharmaceuticals
→ Flat
Stage 2%
50.5%
20d Δ
+0.5pp
1M return
+1.9%
3M return
+11.7%
Industry Stage-2 % · last 20 days
Industry has 53 Stage 2 leaders. See Pharmaceuticals Stage 2 →
Price + Volume Chart
Loading price chart…
Stage Cycle Timeline2026-04-02 → 2026-08-07
S? 18w
2026-04-022026-08-07
S1S2S3S4Setup score (0–10, dashed line at 5)
S? 18w current
Total tracked: 18 weeks across 1 stage run.
1M
-5.9%
3M
+3.3%
6M
—
YTD
—
1Y
—
Scan Membership
Not in any current scan.
Recent Stage Timeline
2026-08-07S—
Wk 18 · Vol —x
2026-08-06S—
Wk 18 · Vol —x
2026-08-05S—
Wk 17 · Vol —x
2026-08-04S—
Wk 17 · Vol —x
2026-08-03S—
Wk 17 · Vol —x
2026-07-31S—
Wk 17 · Vol —x
2026-07-30S—
Wk 17 · Vol —x
2026-07-29S—
Wk 16 · Vol —x
2026-07-28S—
Wk 16 · Vol —x
2026-07-27S—
Wk 16 · Vol —x
2026-07-24S—
Wk 16 · Vol —x
2026-07-23S—
Wk 16 · Vol —x
Sector Peers — Stage 2All →
DIVISLAB
wk 12 · -3.6% from hi
8.5
LAURUSLABS
wk 16 · -0.3% from hi
8.4
PPLPHARMA
wk 4 · 0.0% from hi
8.2
LALPATHLAB
wk 9 · 0.0% from hi
7.9
SHILPAMED
wk 13 · 0.0% from hi
7.8
Moving averages & range
50 DMA
₹15.1
200 DMA
—
52W High
—
52W Low
—
5D Low
₹14.2
Resistance levels (recent highs)
20d High
₹15.9
60d High
₹16.3
120d High
—
250d High
—
Next resistance
+9.1%
to 20d High

All analytics based on EOD data. Data as of 2026-08-07. Past data patterns are not indicative of future results. This page is a data analytics tool only.